AI assistant
Sending…
Pets at Home Group PLC — Director's Dealing 2017
Dec 4, 2017
4909_dirs_2017-12-04_274dc26b-b463-4df6-b8a2-0dd8cc7ea987.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3129Y
Pets At Home Group Plc
04 December 2017
1 December 2017
Pets at Home Group plc
Director/PDMR Shareholding
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| (a) | Name | Sally Hopson | |
| 2. | Reason for the notification | ||
| (a) | Position/status | Chief Executive Officer Vet Group | |
| (b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer | ||
| (a) | Name | Pets at Home Group Plc | |
| (b) | LEI | N/A | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the Financial Instrument | Ordinary shares of £0.01 nominal value each in the capital of Pets at Home Group Plc | |
| (b) | Identification code of the Financial Instrument | GB00BJ62K685 | |
| (c) | Nature of the transaction | Sally Hopson has exercised options over Ordinary Shares in the Company in relation to the 2014 Sharesave. | |
| (d) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £1.40 per share | 6.428 | ||
| (e) | Aggregated information - Aggregated volume - Price |
£8,999.20 | |
| (f) | Date of the transaction | 1 December 2017 | |
| (g) | Place of the transaction | London Stock Exchange (XLON) |
Enquiries:
Louise Stonier
Legal Director and Company Secretary
Pets At Home Group plc
Tel: 0161 486 3590
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKQDNNBDDDBK
More from Pets at Home Group PLC
Earnings Release
2026
May 27
Major Shareholding Notification
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 3
Transaction in Own Shares
2026
Feb 27
Transaction in Own Shares
2026
Feb 26
Transaction in Own Shares
2026
Feb 25
Transaction in Own Shares
2026
Feb 24